… hydroxyproline content and the histologic severity of fibrosis,[13] with a … pulmonary fibrosis,
pirfenidone downregulated HSP47 expression with a parallel reduction in pulmonary fibrosis.[…

… therapies that are currently in various stages of preclinical/clinical development. We will also
focus this discussion on pulmonary fibrosis, in … Two cell-based therapeutic approaches that …

… approach may support the effective and safe use of adjunctive NAC in idiopathic pulmonary
fibrosis, … of NAC suggests a role in the treatment of pulmonary fibrosis induced by COVID-19. …

… Mesenchymal stem cells (MSCs) are one of the most intriguing novel therapeutic
approaches in the field of chronic diseases [75]. In animal models of bleomycin-induced …

… and its accompanied toxicity, the search for additional therapies has intensified in the past
decade. The following is an overview of other therapeutic approaches, most of which are …

… outcome for patients with idiopathic pulmonary fibrosis (IPF) is … : impact of oxygen and
colchicine, prednisone, or no therapy … the treatment of idiopathic pulmonary fibrosis. A randomized …

… The currently accepted approach to treatment of idiopathic pulmonary fibrosis (IPF) is based
… therapy has numerous pitfalls that have to be addressed before we see a real therapeutic …

… mortality rate for pulmonary fibrosis of 50.8 per 1,000,000 persons in the US from 1992 to
2003. Of concern however was the age-adjusted pulmonary fibrosis mortality increase in men …

… lungs and, therefore, reconstitution of FoxO3 pharmacology is currently a novel therapeutic
approach (22). In addition, the IPF-associated endothelial microparticles are other targets …

… approach to diagnostic assessment and therapeutic decision-making for patients … pulmonary
fibrosis understand the different therapeutic approaches for different types of pulmonary …